Trial Profile
Augmentation therapy of resistant postpartum depression with Aripiprazole
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2022
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Postnatal depression
- Focus Therapeutic Use
- 16 Mar 2016 Phase of the study changed from phase II to phase III, according to ClinicalTrials.gov record.
- 16 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 04 Jul 2011 New trial record